We are live on
!
Find out more
JA
JLB & Associates Portfolio holdings
AUM
$696M
1-Year Est. Return
17.86%
This Fund
S&P 500
This Quarter
Est. Return
+1.73%
1 Year Est. Return
+17.86%
3 Year Est. Return
+57.72%
5 Year Est. Return
+93.63%
10 Year Est. Return
–
AUM
$219M
AUM Growth
–
Cap. Flow
+$221M
Cap. Flow
% of AUM
100.59%
Top 10 Holdings %
Top 10 Hldgs %
30.09%
Holding
73
New
73
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
McCormick & Company Non-Voting
MKC
|
+$7.94M |
| 2 |
Gilead Sciences
GILD
|
+$7.72M |
| 3 |
Oracle
ORCL
|
+$7.37M |
| 4 |
Accenture
ACN
|
+$6.95M |
| 5 |
Ametek
AME
|
+$6.69M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 18.21% |
| 2 | Healthcare | 17.02% |
| 3 | Consumer Discretionary | 16.96% |
| 4 | Industrials | 13.16% |
| 5 | Consumer Staples | 11.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
McCormick & Company Non-Voting
MKC
$14.4B
| $7.76M | 3.54% |
+220,524
| New | +$7.94M |
|
|
2
Gilead Sciences
GILD
$174B
| $7.59M | 3.46% |
+148,153
| New | +$7.72M |
|
|
3
Oracle
ORCL
$357B
| $6.82M | 3.11% |
+221,977
| New | +$7.37M |
|
|
4
Ametek
AME
$53.9B
| $6.78M | 3.09% |
+160,205
| New | +$6.69M |
|
5
Mastercard
MA
$485B
| $6.76M | 3.08% |
+117,690
| New | +$6.54M |
|
|
6
Accenture
ACN
$89.1B
| $6.29M | 2.87% |
+87,444
| New | +$6.95M |
|
7
Microsoft
MSFT
$2.92T
| $6.18M | 2.82% |
+179,030
| New | +$5.87M |
|
8
PepsiCo
PEP
$193B
| $6.07M | 2.77% |
+74,269
| New | +$6.06M |
|
9
Amphenol
APH
$182B
| $6.04M | 2.76% |
+620,232
| New | +$5.94M |
|
10
Graco
GGG
$12.7B
| $5.67M | 2.59% |
+269,382
| New | +$5.44M |
|
11
Polaris
PII
$4.24B
| $5.49M | 2.5% |
+57,795
| New | +$5.23M |
|
12
Rollins
ROL
$22.2B
| $5.07M | 2.31% |
+661,233
| New | +$4.75M |
|
13
Ross Stores
ROST
$75.8B
| $5.07M | 2.31% |
+156,506
| New | +$5.01M |
|
14
Nike
NKE
$66.5B
| $5.02M | 2.29% |
+157,572
| New | +$4.9M |
|
15
Cognizant
CTSH
$21.3B
| $4.83M | 2.2% |
+154,090
| New | +$5.12M |
|
16
NewMarket
NEU
$7.14B
| $4.82M | 2.2% |
+18,340
| New | +$4.95M |
|
17
Stryker
SYK
$126B
| $4.76M | 2.17% |
+73,584
| New | +$4.88M |
|
18
SEI Investments
SEIC
$12.1B
| $4.66M | 2.13% |
+163,944
| New | +$4.75M |
|
|
EV
19
DELISTED
Eaton Vance Corp.
EV
| $4.59M | 2.09% |
+122,128
| New | +$4.91M |
|
20
Occidental Petroleum
OXY
$54.6B
| $4.59M | 2.09% |
+53,665
| New | +$4.53M |
|
|
VAR
21
DELISTED
Varian Medical Systems, Inc.
VAR
| $4.48M | 2.04% |
+75,794
| New | +$4.54M |
|
|
BCR
22
DELISTED
CR Bard Inc.
BCR
| $4.41M | 2.01% |
+40,584
| New | +$4.22M |
|
23
Silgan Holdings
SLGN
$5.09B
| $4.31M | 1.97% |
+183,572
| New | +$4.39M |
|
|
OA
24
DELISTED
Orbital ATK, Inc.
OA
| $4.29M | 1.96% |
+52,119
| New | +$3.95M |
|
|
K
25
DELISTED
Kellanova
K
| $4.05M | 1.85% |
+67,162
| New | +$4.05M |
|
Similar funds
AAM
CA
CA
FCM
GUB
AWC
BBPWM
SCM
JLB & Associates's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for JLB & Associates, which disclosed 73 positions worth $219M. Its ten largest holdings account for 30% of the portfolio.
Its largest position is McCormick & Company Non-Voting: 220,524 shares worth $7.76M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, followed by Healthcare and Consumer Discretionary.
- JLB & Associates's largest Q2 2013 buy was McCormick & Company Non-Voting: 220,524 shares worth $7.76M.
- JLB & Associates's ten largest holdings make up 30% of its $219M portfolio in Q2 2013.
- JLB & Associates disclosed 73 positions in Q2 2013, its first 13F filing on record.
Based on JLB & Associates's 13F filing for Q2 2013, filed 12 Aug 2013.